We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Partnership for High Intensity Focused Ultrasound

By HospiMedica staff writers
Posted on 16 Jan 2006
Siemens Medical Solutions (Erlangen, Germany) and Chongqing Haifu (HAIFU) Technology Co., Ltd. More...
(Chongqing, People's Republic of China) have signed a contract to jointly develop a magnetic resonance imaging- (MRI)-guided high intensity focused ultrasound (HIFU) therapy system.

The goal of the collaboration is to combine Haifu's therapy technology with Siemens' expertise in high-field MRI technology. Key applications include women's health treatments such as benign uterine fibroids and cancer as well as malignant and benign tumors of the liver, kidney, pancreas, and bone. The equipment and process have already received CE marking after a series of liver and kidney trials at the Churchill Hospital, Oxford, UK.

The collaboration between Siemens and HAIFU includes the ability to precisely visualize temperature distributions inside the human body. Further developments involve MR applications for diagnosis, therapy planning, as well as outcome assessment. Patient treatment will be performed on a special HIFU patient bed inside the bore of Siemens' range of high field scanners.

Haifu's distributor outside the Far East is Ultrasound Therapeutics, Ltd. (www.utlltd.com). Haifu provides a broad spectrum of applications in research and clinical practice. The inability to treat large tissue volumes in short timescales with good visualization of the target volume has hindered the clinical acceptance of the technique. Haifu has been able to develop a technology that overcomes this limitation.

Prof. Zhibiao Wang, President of Haifu stated, "We have had great international success with US-guided HIFU treatment but we believe that MR-guided HIFU will provide an added direction and more options with Siemens advanced MR technology and offer more exciting developments for the future of HIFU technology.”

Chongqing Haifu (HIFU) Technology Co. Ltd. has its own Clinical Center for Tumor Therapy and cooperates with the Institute of Ultrasound Engineering in Medicine at Chongqing University of Medical Sciences.




Related Links:
Siemens Medical Solutions
Chongqing Haifu Technology

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Pulmonary Ventilator
OXYMAG
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.